191 related articles for article (PubMed ID: 7745513)
1. One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
Saigal S; Robertson C; Sankaran K; Bingham W; Casiro O; MacMurray B; Whitfield M; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S61-7. PubMed ID: 7745513
[TBL] [Abstract][Full Text] [Related]
2. One-year follow-up of 89 infants with birth weights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group. Canadian Exosurf Neonatal Follow-Up Group.
Casiro O; Bingham W; MacMurray B; Whitfield M; Saigal S; Vincer M; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S53-60. PubMed ID: 7745512
[TBL] [Abstract][Full Text] [Related]
3. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
[TBL] [Abstract][Full Text] [Related]
4. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Gong A; Anday E; Boros S; Bucciarelli R; Burchfield D; Zucker J; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S68-74. PubMed ID: 7745514
[TBL] [Abstract][Full Text] [Related]
5. Outcome at 1-year adjusted age of 957 infants weighing more than 1250 grams with respiratory distress syndrome randomized to receive synthetic surfactant or air placebo. American and Canadian Exosurf Neonatal Study Groups.
Sauve R; Long W; Vincer M; Bard H; Derleth D; Stevenson D; Pauly T; Robertson C
J Pediatr; 1995 May; 126(5 Pt 2):S75-80. PubMed ID: 7745515
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
Walther FJ; Mullett M; Schumacher R; Sundell H; Easa D; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
[TBL] [Abstract][Full Text] [Related]
8. Double-blind evaluation of developmental and health status to age 2 years of infants weighing 700 to 1350 grams treated prophylactically at birth with a single dose of synthetic surfactant or air placebo.
Kraybill EN; Bose CL; Corbet AJ; Garcia-Prats J; Asbill D; Edwards K; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S33-42. PubMed ID: 7745509
[TBL] [Abstract][Full Text] [Related]
9. Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II.
Gerdes J; Gerdes M; Beaumont E; Cook L; Dhanireddy R; Kopleman A; Jarret R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S26-32. PubMed ID: 7745508
[TBL] [Abstract][Full Text] [Related]
10. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
[TBL] [Abstract][Full Text] [Related]
11. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
[TBL] [Abstract][Full Text] [Related]
12. Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I.
Corbet A; Long W; Schumacher R; Gerdes J; Cotton R
J Pediatr; 1995 May; 126(5 Pt 2):S5-12. PubMed ID: 7745511
[TBL] [Abstract][Full Text] [Related]
13. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
[TBL] [Abstract][Full Text] [Related]
19. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
